Suman, Arnela https://orcid.org/0000-0003-0656-490X
van Es, Jasmijn
Gardarsdottir, Helga
Grobbee, Diederick E.
Hawkins, Kimberly
Heath, Megan A.
Mackenzie, Isla S.
van Thiel, Ghislaine
Zuidgeest, Mira G. P.
,
Funding for this research was provided by:
Innovative Medicines Initiative (831458)
Article History
Received: 7 November 2021
Accepted: 1 September 2022
First Online: 6 October 2022
Declarations
:
: Given the scope of this study, i.e. a questionnaire survey among organisations being partners in a consortium, ethics approval requirements were waived. Participation in the survey by the organisations was voluntary, and consent was implied by a returned questionnaire.
: All participating organisations were informed about the publication of the results, and all were sent the draft manuscript before submission. Through a previously agreed upon and standardised consortium publication approval procedure, each party had the opportunity (during 30 days) to object to the publication. No objections were received to the publication of this manuscript.
: The authors declare that they have no competing interests.